Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INCB047986 in active rheumatoid arthritis
NCT02151474Phase 2Terminated
- Sponsor
- Incyte
- Start
- May 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of INCB047986 in rheumatoid arthritis (RA), sponsored by Incyte. Started May 2014; status: terminated.
02
Drugs
INCB047986
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT02151474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02151474.